Morse Asset Management’s Allergan plc AGN Stock Holding History

Morse Asset Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-6,628	Closed	-$1.58M	–	142
2017 Q1	$1.58M	Buy	+6,628	New	+$1.54M	0.54%	60

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morse Asset Management's AGN Position: Q2 2017 in Review

Morse Asset Management sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 6,628 shares — an estimated $1.58M sold.

Morse Asset Management first reported a position in AGN in Q1 2017 and held it in 1 quarter. The position peaked at $1.58M in Q1 2017. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

Morse Asset Management reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
Morse Asset Management sold 6,628 Allergan plc shares in Q2 2017, an estimated $1.58M.
Morse Asset Management first reported a position in Allergan plc in Q1 2017 and held it in 1 quarter.
Morse Asset Management's Allergan plc position peaked at $1.58M in Q1 2017.
1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Morse Asset Management's 13F filing for Q2 2017, filed 1 Aug 2017.